Public Profile

Synthon

Synthon, officially known as Synthon B.V., is a leading pharmaceutical company headquartered in the Netherlands. Founded in 1991, Synthon has established a strong presence in the global pharmaceutical industry, focusing on the development and manufacturing of complex generics and innovative medicines. With operational regions spanning Europe and beyond, the company is renowned for its expertise in the production of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. Synthon's core offerings include a diverse range of generic products, particularly in oncology and central nervous system therapies, distinguished by their quality and affordability. The company has achieved significant milestones, including numerous successful product launches and partnerships, solidifying its position as a trusted player in the market. With a commitment to innovation and excellence, Synthon continues to contribute to improved patient outcomes worldwide.

DitchCarbon Score

How does Synthon's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

3

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

6

Industry Benchmark

Synthon's score of 3 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.

1%

Synthon's reported carbon emissions

Synthon, headquartered in the Netherlands (NL), currently does not have publicly available carbon emissions data for the most recent year. As a result, specific figures regarding their emissions in kg CO2e, including Scope 1, 2, or 3 emissions, are not provided. Despite the absence of detailed emissions data, Synthon is committed to addressing climate change through various initiatives. However, no specific reduction targets or climate pledges have been disclosed. This indicates that while Synthon may be aware of the importance of sustainability, further information on their climate commitments and strategies would be necessary to assess their overall impact on carbon emissions and their approach to climate action.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Synthon's primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Synthon is headquartered in NL, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Synthon is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Health Services

Collini GmbH

AT
Health Services
Updated 11 days ago

Poppy Nursing Services

GB
Health Services
Updated 11 days ago

Alibaba Health

CN
Health Services
Updated 11 days ago

Medical Protection Society

GB
Health Services
Updated 10 days ago
CDP

Renjian Pharmaceuticals

CN
Health Services
Updated 11 days ago

MolecularMD Corp.

US
Health Services
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers